CAVALIER JASON (Chief Financial Officer) reported 1 transaction at LYRA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/3/2026ACC: 0001193125-26-142099
Officer· Chief Financial Officer
Since Sep 2021
-667.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
667.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−667.00
Price / share
—
Trade value
—
% of position
0.1%
4/1/2026
518.55K→517.88K
Total
Net shares
−667.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | D · Disposition | −667.00 | — | — | 0.1% | 518.55K | 517.88K |
| Total | −667.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported